LONDON--(BUSINESS WIRE)--The global cerebral and tissue oximetry devices market is poised to grow by USD 51.31 million during 2020-2024, progressing at a CAGR of about 7% during the forecast period. Request free sample pages
Read the 120-page report with TOC on "Cerebral and Tissue Oximetry Devices Market Analysis Report by Product (Modular devices and Handheld devices), Geographic Segmentation (North America, Europe, Asia, and ROW), and the Segment Forecasts, 2020-2024".
The market is driven by the growing use of cerebral and tissue oximetry devices in cardiac surgical procedures. In addition, technological advancements in cerebral and tissue oximetry devices are anticipated to boost the growth of the cerebral and tissue oximetry devices market.
The demand for efficient treatment in healthcare settings for CVDs is increasing due to the prevalence of rheumatic heart diseases, cardiomyopathy, and cerebrovascular diseases. Number of cardiac surgeries performed in healthcare settings is also increasing with the growing urgency in surgical interventions. Patients undergoing cardiac surgeries are more prone to adverse perioperative neurological events as the anesthesia delivered to the them can lead to oxygen deprivation/cerebral hypoxia. As a result, the demand for advanced blood oxygenation monitoring devices such as cerebral and tissue oximetry devices is increasing to help avoid complications related to cerebral hypoxia. Thus, the growing use of cerebral and tissue oximetry devices in cardiac surgical procedures is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Cerebral and Tissue Oximetry Devices Market Companies:
Edwards Lifesciences Corp.
Edwards Lifesciences Corp. operates the business under various segments such as Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy, and Critical Care. The company offers ForeSight Elite system, which is a noninvasive monitoring technology.
Hamamatsu Photonics KK
Hamamatsu Photonics KK offers products through the following business units: Electron Tube, Opto-semiconductor, and Imaging and Measurement Instruments. The company offers NIRO-200NX, which is a monitor that uses near infrared spectroscopy.
HyperMed Imaging Inc.
HyperMed Imaging Inc. offers innovative solutions for superficial tissue oximetry applications. The company offers HyperView, which is a handheld, battery operated, portable diagnostic imaging device. It is used as a noninvasive tissue oxygenation measurement system.
ISS Inc. offers products through the following business segments: Fluorescence, Microscopy, and Biomedical. The company offers OxiplexTS, which is a tissue oximeter. This device is used to measure the oxygenated and de-oxygenated hemoglobin concentrations in the tissue.
Masimo Corp. is involved in the production and supply of a range of patient monitoring and related products. The company offers Root platform, which is a patient monitoring and connectivity platform. It enables clinicians to monitor patients who are under anesthesia or sedation.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Cerebral and Tissue Oximetry Devices Market Product Outlook (Revenue, USD Million, 2020-2024)
- Modular devices
- Handheld devices
Cerebral and Tissue Oximetry Devices Market Geographic Outlook (Revenue, USD Million, 2020-2024)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.